Analysis of CHEK2 gene for ovarian cancer susceptibility

Gynecologic Oncology
Bora E BaysalHolly H Gallion

Abstract

A deletion variant in the CHEK2 gene (del1100C) has been implicated as a low-penetrance risk factor for breast cancer. We sought to determine contribution of CHEK2 mutations to the etiology of ovarian cancer (OvCa). We used cases ascertained from the United States through Gynecologic Oncology Group (GOG) protocols 172, 182, and 144, the University of Hawaii Cancer Research Center, and Creighton University. Control women were recruited from Pittsburgh and Hawaii. Denaturing high-performance liquid chromatography, sequence analysis, and single nucleotide polymorphism genotyping by Pyrosequencing were employed to analyze the CHEK2 gene. Mutation screening of the CHEK2 gene in 48 cases who had a first-degree relative with OvCa uncovered only del1100C and A252G variants. Altogether, the del1100C variant was detected in none of 751 unselected cases, in 1 of 52 (1.9%) cases who had a first-degree relative with OvCa, and in 3 of 521 (0.6%) unselected controls. The frequencies of del1100C and A252G variants did not show statistically significant differences between the cases and the controls. These results suggest that variations in CHEK2 do not make a significant contribution to the pathogenesis of OvCa in the U.S. population.

References

Sep 13, 1996·Science·N Risch, K Merikangas
Aug 27, 1998·American Journal of Human Genetics·K W BromanJ L Weber
Apr 10, 1999·Human Molecular Genetics·S A JanezicH Anton-Culver
Mar 22, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R J Edmondson, J M Monaghan
Apr 13, 2002·Blood·Akira HangaishiHisamaru Hirai
Apr 23, 2002·Nature Genetics·Hanne Meijers-HeijboerUNKNOWN CHEK2-Breast Cancer Consortium
Jul 3, 2002·American Journal of Human Genetics·Pia VahteristoHeli Nevanlinna
Jul 12, 2002·Nature·Elisabeth DawsonIan Dunham
Jul 12, 2002·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Clare H McGowan
Sep 19, 2002·Journal of the National Cancer Institute·Jeffrey L HiltonRichard E Buller
Jan 21, 2003·American Journal of Human Genetics·Xiangyang DongWanguo Liu
Mar 1, 2003·American Journal of Human Genetics·Mieke SchutteUNKNOWN Breast Cancer Linkage Consortium
Apr 12, 2003·American Journal of Human Genetics·Hanne Meijers-HeijboerMieke Schutte
Oct 22, 2003·Journal of Medical Genetics·O KilpivaaraH Nevanlinna
Oct 25, 2003·Science·Mary-Claire KingUNKNOWN New York Breast Cancer Study Group
Nov 18, 2003·International Journal of Cancer. Journal International Du Cancer·Ana OsorioJavier Benítez
Apr 20, 2004·International Journal of Cancer. Journal International Du Cancer·Michael R DufaultNorbert Arnold

❮ Previous
Next ❯

Citations

Dec 14, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Deborah ThompsonDouglas F Easton
Apr 3, 2009·Hereditary Cancer in Clinical Practice·Evgeny N SuspitsinEvgeny N Imyanitov
Jan 1, 2007·Hereditary Cancer in Clinical Practice·Nadezhda Yu KrylovaEvgeny N Imyanitov
Sep 26, 2006·Oncogene·H Nevanlinna, J Bartek
Dec 16, 2006·Leukemia & Lymphoma·Gabrielle S SellickRichard S Houlston
Jan 28, 2015·Gynecologic Oncology·Lindsey E MinionBradley J Monk
Oct 22, 2008·Seminars in Oncology·George A Omura, UNKNOWN Gynecologic Oncology Group
Jun 7, 2011·Biochimica Et Biophysica Acta·M G M BraemN C Onland-Moret
Jun 16, 2015·BioMed Research International·Angela TossLaura Cortesi
Jun 15, 2016·Nature Reviews. Clinical Oncology·Nadine TungMark E Robson
Dec 13, 2005·Cancer Genetics and Cytogenetics·Ans BaeyensAnne Vral
Jul 22, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas C KrivakUNKNOWN Gynecologic Oncology Group Phase III Trial
May 18, 2019·Clinical Genetics·Nicola FlaumDafydd G Evans
Jan 18, 2019·Journal of Human Genetics·Ana KrivokucaMirjana Brankovic-Magic
Feb 13, 2020·International Journal of Molecular Sciences·Davide AngeliGianluca Tedaldi
May 6, 2019·International Journal of Cancer. Journal International Du Cancer·Petra KleiblovaZdenek Kleibl
Feb 7, 2020·NPJ Genomic Medicine·Fawz S AlHarthiMalak Abedalthagafi
Feb 3, 2021·NPJ Genomic Medicine·Fawz S AlHarthiMalak Abedalthagafi
Jul 3, 2021·Biomedicines·Mihaela Raluca RaduViorica Elena Rădoi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.